Madrigal Pharmaceuticals, Inc. (MDGL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 4.22B |
| Enterprise value | 3.70B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 10.40 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -10.27 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.44 |
| 52-week change 3 | -33.64% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 314.79 |
| 52-week low 3 | 119.76 |
| 50-day moving average 3 | 241.97 |
| 200-day moving average 3 | 201.45 |
Share statistics
| Avg vol (3-month) 3 | 602.34k |
| Avg vol (10-day) 3 | 471.82k |
| Shares outstanding 5 | 20.97M |
| Implied shares outstanding 6 | 20.97M |
| Float 8 | 12.78M |
| % held by insiders 1 | 9.24% |
| % held by institutions 1 | 94.74% |
| Shares short (15 Apr 2024) 4 | 3.41M |
| Short ratio (15 Apr 2024) 4 | 6.17 |
| Short % of float (15 Apr 2024) 4 | 19.29% |
| Short % of shares outstanding (15 Apr 2024) 4 | 16.24% |
| Shares short (prior month 15 Mar 2024) 4 | 3.26M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 25 Jul 2016 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:35 |
| Last split date 3 | 25 Jul 2016 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -47.41% |
| Return on equity (ttm) | -123.98% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -379.97M |
| Net income avi to common (ttm) | -373.63M |
| Diluted EPS (ttm) | -19.99 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 634.13M |
| Total cash per share (mrq) | 31.87 |
| Total debt (mrq) | 117.19M |
| Total debt/equity (mrq) | 28.91% |
| Current ratio (mrq) | 5.38 |
| Book value per share (mrq) | 20.39 |
Cash flow statement
| Operating cash flow (ttm) | -324.23M |
| Levered free cash flow (ttm) | -192.38M |
© 2024 Yahoo. All rights reserved.